Articles

Primary Gasterointestinal Lymphoma, Clinicopathologic Study of 49 Small Intestinal Lymphoma Casess and the Treatment Option of Choice

Abstract

Introduction: A study was made conserning 142 patients who were suffering from gastrointestinal lymphoma, were seen at the department of Hematology and Oncology, Esfahan Medical School, during the period 1982-2002.
Method: All patients had laparotomy, and biopsy of the site lesion. Histopathological subtypes were done in the International Working Formulation. Stage groupings were done applying the Crowther and Blackledge staging system. The post-laparotomy was made depending on the patient's general condition, the completeness of surgery and histological subtype.
Results: There were 52 cases of gastrointestinal lymphoma in the stomach, 49 in the small intestine, 12 in the ileocecal region, 22 in the rectosigmoid and in seven of the cases, multiple sites in the gastrointestinal tract were involved.
Conclusion: The overall survival rate was 47.8% at 5 years. Early stage disease and high-grade lymphoma have a better prognosis if treated adequately. Patients who had complete surgical removal of primary tumour (befor any metastasis) had a longer survival.

Devita, Jr VT, Hellman S & Rosenberg SA Cancer: Principles and Practice of Oncology. 5th ed. Philadelphia, Pa: Lippincott-Raven; 1997:2170-2236.

Moossa AR, Schimpff SC & Robson MC Comprehensive Textbook of Oncology (Vols 1-2). 2nd ed. Baltimore, Meryland: Williams and Wilkins; 1991.

Brady LW, Asbell SO, Malignant Lymphoma of the Gastrointestinal Tract. Erskine Memorial Lecture, 1979. Radiology, 1980; 137: 291-298.

Lewin KJ, Ranchod M, Dorfman RF. Lymphomas of the Gastrointestinal Tract: A Study of 117 Cases Presenting with Gastrointestinal Disease. Cancer, 1978;42:697.

Malik IA, Shamsi Z, Shafquat A, Aziz Z, Shaikh H, Jafri W, Khan MA, Khan AH.. Clinicopatological Features and Mamagement of Immunoprolifrative Small Intestinal Disease and Primary Small Intestinnal Lymphoma in Pakistan. Med PediatrOncol,1995;25(5):400-6.

Gospadarowichz MK, Bush RS, Brown TC. Curability of Gastroitestinal Lymphoma with Combined Surgery and Radiation. Int J Radiat Oncol Biol Phys 1983; 9 (1):3-9.

Milanovic N, Jelic S, Jovanovic V, kovcin.V, Opric M, et al. Non-IPSID Small Intestinal Lymphoma: Evidence for Disseminated Disease at Presentation. Neoplasma,1994; 41 (6): 359-62.

Crowther DA,Blackledge G.Gastrointestinal Lymphoma. Br J Radiol, 1978: 51:600-601.

Fleming ID, Mitchel S,Dilawari RA. The Role of Surgery in the Management of Gastric Lymphoma. Cancer, 1982;49:1135-1141.

Varghese C, Jose CC, Subhashini J, Roul RK. Primary Small Intestinal Lymphoma. Oncology, 1992; 49; 340-342.

Shephered AF, Evans NK, Kutas G, Yan JC, Dang JP, et al. Chemotherapy Following Surgery for Stages IE and IIE non-Hodgkin's Lymphoma of Gastrointestinal Tract.J Clin Oncol, 1987;6: 253-260.

Radaszkiewicz T, Dragosics B, Bauer P. Gastrointestinal Malignant Lymphomas of the Mucosa- associated Lymphoid Tissue: Factors Relevant to Prognosis. Gastroentrol. 1992; 101:1159.

Haber, DA, Mayer, RJ. Primary Gastrointestinal Lymphoma.Semin Oncol 1988; 15:154.

Shih LY, Liaw SJ, Dunn P, Kuo TT.: Primary Small- intestinal Lymphomas in Taiwan: Immunoprolifrative Small-intestinal Disease and Nonimmunoprolifrative Small-intestinal Disease. J Clin Oncol. 1994, Jul; 12(7):1375-82.

Barista I, Tekuzman G, Firat D, et al. Non-Hodgkin's Lymphomas in Turkey: Eighteen Years' Experience at the Hacettepe University. Jpn J Cancer Res. 1994 Dec;85(12):1200-7.

Files
IssueVol 3, No 4 (2009) QRcode
SectionArticles
Keywords
Non Hodgkin's Lymphoma Small Intestinal Pimary Treatment

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Azarm T, Mohajer H, Daghaghzadeh H, Alimoghaddam K, Jahani M, Ghavamzadeh A. Primary Gasterointestinal Lymphoma, Clinicopathologic Study of 49 Small Intestinal Lymphoma Casess and the Treatment Option of Choice. Int J Hematol Oncol Stem Cell Res. 1;3(4):21-23.